Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • High throughput platforms to characterize a bispecific antibody subjected to force degradation
bispecific-antibody1920x640
Application Note

High throughput platforms to characterize a bispecific antibody subjected to force degradation

Forced degradation studies are critical in therapeutic antibody research, helping to evaluate stability across the product lifecycle. Common degradation pathways include aggregation, deamidation, oxidation, and fragmentation, with thermal stress being a frequently studied factor.

This application note explores the stability of a bispecific antibody targeting mouse CD200 and CD47 under thermal stress, using a high-throughput, no-wash HTRF™ assay to assess its binding activity.

Read this application note to learn more.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Download Resource

High throughput platforms to characterize a bispecific antibody subjected to force degradation

Download Application Note
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.